New research detects a growing trend of antibody evasion by new omicron subvariants

Treating acne with systemic antibiotics can have unintended consequences on maturing adolescent skeleton
22 November 2022
New study brings personalized immunotherapy prescriptions a step closer
22 November 2022

New research detects a growing trend of antibody evasion by new omicron subvariants

Three currently circulating omicron subvariants of SARS-CoV-2—including two that currently make up almost 50% of reported COVID-19 infections in the U.S.—are better at evading vaccine- and infection-generated neutralizing antibodies than earlier versions of omicron, suggests new research published in Cell Host & Microbe.

Comments are closed.